DMGGF yields 1185.54% · PFE yields 6.13%● Live data
📍 DMGGF pulled ahead of the other in Year 1
Combined, DMGGF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of DMGGF + PFE for your $10,000?
DMG Blockchain Solutions Inc. operates as a blockchain and cryptocurrency company in Canada. The company manages, operates, and develops digital solutions to monetize the blockchain ecosystem. It also offers transaction verification; co-location hosting; data center optimization; and high-performance computing services. In addition, the company provides infrastructure consulting in various fields, including location and power infrastructure review, air flow and cooling contact, high and low voltage power design and engineering, and facility power distribution design and engineering. Further, the company develops and licenses proprietary blockchain and cryptocurrency software, comprising Mining Pool, an audited mining pool; WalletScore, a blockchain audit and analytics platform; Mine Manager, an optimization software for mining facilities; Blockseer Intelligence, an analytics tool that enables the tracking of cryptocurrency on Bitcoin and Ethereum blockchains; Blockseer Breeze, an enterprise-grade custody solution to securely manage digital assets; and BlockSeer Freeze, a software product that watches BTC wallets and provides early notification of transactions on the blockchain network. Additionally, it offers forensic services. The company was incorporated in 2011 and is headquartered in Grand Forks, Canada.
Full DMGGF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.